j PROCESSED AT :

Thyrocare
413, Block B,
Thyro care
Chinarr Fortune City,
Hoshangabad Road,Bhopal-462 003
The Trust. The Tru th .

Corporott otfict : Thyrocare l echnologlei Limited, 9 D-37i3, ·1TC MIDC, lur'l ihe, Navr Mumbai · 400 703
(9 022 • 3090 0000 / 67 12 J.!00 !9 987 0666333 ,:, v, ellM1s(ii>1hyr oca 1e.corn (fr) www.lhyrocare.com

NAME
SMT SARLA PATHAK (BlY/F)
REF.BY SAMPLE COLLECTED AT:
SELF
(4610010672),CHIRAG DIAGNOSTICS
TEST ASKED AAROGYAM B PRO CENTRE,BETUL ROAD, P URAN! !TARSI , !TARSI,
HOSHSNGABAD,461111

TEST NAME
TECHNOLOGY VALUE UNITS
IRON
PHOTOMETRY 40.1
Reference Range : 1,19/dl
Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC)
PHOTOMETRY 286,8 µg/dl
Reference Range :
Male: 225 - 535 µg/dl Female : 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
0/o TRANSFERRIN SATURATION CALCULATED 13.98 %
Reference Range :
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES
Please correlate with clinical conditions.

Sample Collected on (SCT)

:11 Feb 2022 09:10
Sample Received on (SRT)
: 11 Feb 2022 16: 15
Report Released on (RRT)
: 11 Feb 2022 21:31
Sample Type f!l:~~f!J
.. '»-j,' , :SERUM
Labcode
Barcode
. ..
I,,.;~~--
@ •· · ··
...-j ;

:
:1102078556/AD962
: X1287630·
Dr.Prachi Sinkar MD(Path)
Dr.Caesar Sengupta MD(Micro)

Page : 1 of9
 PROCESSED AT :
Thyrocare
413, Block 8,
Chlnarr Fortune City
Thyro care
Hoshangabad Road
003 '
Bh opal-462 The Trust . The Truth.

Corporatr O/flcr . Th
© 022 . yrourt Ttchnoloeles llm ltitd 9
• J090 0000 / 6712 3400 (9 9 0(; ' D•Jl/l, TIC MI0C, furbhe, Na~, Mumb.il . 400 70J
87 663
.lJ wellnI'l l.,. ,, rocare.tom
"" (,"'· e WWW lhyroc.irr.com
• • 1':
NAME
: SMT SARLA PATHAK (BlY/F)
REF.BY SAMPLE COLLECTED AT:
: SELF
TEST ASKED (4610010672),CHIRAG DIAGNOSTICS CENTRE,BETUL
: AAROGYAM B PRO ROAD, P URANI !TARSI, ITARSI, HOSHSNGABAD,46111!

TEST NAME
TOTAL CHOLESTEROL TECHNOLOGY VALUE UNITS
NORMAL RANGE
HDL CHOLESTEROL - DIRECT PHOTOMETRY 152 < 200
mg/di
PHOTOMETRY 67 40-60
LDL CHOLESTEROL - DIRECT mg/di
TRIGLYCERIDES PHOTOMETRY 75 < 100
mg/di
PHOTOMETRY 64 < 150
TC/ HDL CHOLESTEROL RATIO mg/di
CALCULATED 2.3 Ratio 3-5
LDL / HDL RATIO
CALCULATED 1.1 Ratio 1.s-3.S
NON- HDL CHOLESTEROL
CALCULATED 85.47 mg/di < 160
VLDL CHOLESTEROL
CALCULATED 12.7 mg/di 5 - 40
Please correlate with clinical conditions.

Method:
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
LDL - DIRECT MEASURE
TRI G - ENZYMATIC, END POINT
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
•REFERENCE RANGES AS PER NCEP ATP III GUIDEUNES:
(mg/di) TRIGLYCERIDES (mg/di)
(mg/di) HDL (mg/di) LDL
TOTAL CHOLESTEROL
OPTIMAL <100 NORMAL <150
<200 LOW <40
DESIRABLE
NEAR OPTIMAL 100-129 BORDERLINE HIGH 150·199
200-239 HIGH >60
BORDERLINE HIGH
BORDERLINE HIGH 130-159 HIGH 200-499
>240
HIGH HIGH 160-189 VERY HIGH >500

VERY HIGH >190

- -, - .12 - ho~
- rs fasting Is mandatory for lipid parameters. If not, values might fluctuate.
Alert I 110

~ ollected on (SCT) : 11Feb202209:10

sample Received on (SRT) : 11 Feb 2022 16:15
Report Released on (RRT) : 11 Feb 2022 21:31
sample Type : SERUM
: 1102078556/AD962 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
1.abcode
earcode : X1287630 Page: 2 of9
, PROCESSED AT:
Thyrocare
413, Block B,
Chlnarr Fortune City,
Thyro care
Hoshangabad Road Bh
003 ' opal- 462 The Trnst. The Truth.
C0rp0rotr officr . Th
C9 022 • 3090 · v•oc~,. Tl!Chnoloel•• limit~ 9

NAME
=66333 -~ D-JJ/3, TIC MIDC, 1u1bhe, Nav, Mumbai . 400 703
o;o weflnes1@thyroca ,e.com (lll www.lhyrou,e.com

REF. BY : SMT SARI.A PATHAK (81Y/F) • •I •

: SELF
TEST ASKED SAMPLE COLLECTED AT :
: AAROGYAM B PRO (4610010672),CHIRAG DIAGNOSTICS CENTRE,BETUL
ROAD, P URAN! ITARSI, !TARSI, HOSHSNGABAD,46111l
TESTNAME

LKAUNE PHOSPHATASE
BIURUBIN - TOTAL
BIURUBIN -DIRECT
--

=======::J~:HNioi:m;~---;;~=:---------~-;:-:~:;-
TECHNOLOGY
PHOTOMETRY
VALUE
46.8
UNITS NORMAL RANGE

PHOTOMETRY U/L 45 - 129

BIURUBIN (INDIRECT) 0.38 mg/di 0.3-1.2
PHOTOMETRY
0.08 mg/di
GAMMA GLlJTAMYL TRANSFERASE G CALCULATED < 0.3
0.3
ASPARTATE AMINOTRANSFERA ( GTI PHOTOMETRY mg/di 0-0.9
ALA SE (SGOT ) 10.3 U/1
NINE TRANSAMINASE (SGPT) PHOTOMETRY < 38
13.9 U/1
PROTEIN - TOTAL PHOTOMETRY < 31
11.9 U/1 < 34
ALBUMIN - SERUM PHOTOMETRY 6.2 qm/dl 5.7-8.2
SERUM GLOBULIN PHOTOMETRY 3.58 gm/di 3.2-4.8
SERUM ALB/GLOBULIN RATIO PHOTOMETRY 2.62 gm/dl 2.5-3.4
CALCULATED 1.37
Please correlate with clinical conditions. Ratio 0.9 - 2

Method:
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BIURUBIN VALUES
GGT - MODIFIED IFCC METHOD
SGOT - !FCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG 1 METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR • DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

sarnple Collected on (SCT) : 11 Feb 2022 09:10

sarnple Received on (SRT)
Report Released on (RRT)
sarnple Type
: 11 Feb 2022 16:15
: 11 Feb 2022 21:31
: SERUM
1~
a.abcode : 1102078556/AD962 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
sarcode : X1287630
Page : 3 of9
 p/locESSED AT:
-rhvrocare
413, Block B, Thyro care
Chinarr Fortune City,
Hoshangabad Road,Bhopal- 4 G2 The Trust. The Truth.
003

Corporott offic~ . Th
© . yrocare Ttthnoloales limited 9
022 • 3090 0000 / 6712 1400 (9 98 70666333, ~ -37/3, TTC MIDC, lurbhe, Navr Mumbai . 400 703
_
'"" wellness@ lhyroca,e. com ~r;.
r,'f"'IP,,.,..._ \Ir' www.th yroure.rom

NAME
: SMT SARLA PATHAK (BlY/F)
SAMPLE COLLECTED AT :
REF. BY : SELF {4610010672),CHIRAG DIAGNOSTICS CENTRE,BETUL
TEST ASKED : AAROGYAM B PRO ROAD, P URAN! !TARSI, !TARSI, HOSHSNGABAD,461111

TEST NAME NORMAL RANGE

TECHNOLOGY VALUE UNITS
BLOOD UREA NITROGEN (BUN) 7- 25
PHOTOMETRY 15.43 mg/di
CREATININE - SERUM 0.5-0.8
PHOTOMETRY 0.62 mg/di
BUN/ SR.CREATININE RATIO CALCULATED 24.89 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 9.38 mg/di 8.8-10.6
URIC ACID PHOTOMETRY 4.05 mg/di 3.2 - 6.1
SODIUM I.S.E 130.7 mmol/1 136 -145
POTASSIUM I.S.E 5.22 mmol/1 3.5- s.1
1.5.E 98.2 mmol/1 98 - 107
CHLORIDE
Please correlate with clinical conditions.

Method:
BUN - KINETIC UV ASSAY.
SCRE - CREATININE ENZYMATIC METHOD
8/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD
SOD - ION SELECTIVE ELECTRODE
POT - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

: 11 Feb 2022 09: 10

~ lected on (SCT)
: 11 Feb 2022 16:15
sample Received on (SRT)
: 11 Feb 2022 21:31
fleport Released on (RRT)
: SERUM
sample Type Dr.Caesar Sengupta MD(Micro)
: 1102078556/AD962 Dr.Prachi Sinkar MD(Path)
Labcode
: X1287630 Page: 4 of9
sarcode
- ·· r•v111..c1re
413, Block B

Chinarr Forn:n.
Hoshangabad RoCity, Thyrocare·
ad,Bhopal-462 003 Th 1i Th
'POrott o/fit~ . n,._ .
ti\ o22.
Cot .· ·'"TllJQ,e T@chnolocits llmlttd o e rust. e Truth.
"' · l09o 0000 / 6712 3<0o © 9870666 ' · •31/3, rrc '"De, '""'''·
""'M,m,., •40070,
NAME 333 wellness@thvrocare.com f!WWw.thy1ocarc.com
REF.By SMT SARLA PATHAK (81Y/F)
SELF
TEST ASKED SAMPLE COLLECTED AT :
AAROGYAM B PRO (4610010672),CHIRAG DIAGNOSTICS CENTRE,BErUL
ROAD, P URAN! !TARSI, !TARSI, HOSHSNGABAD,461111

TEST NAME
TECHNOLOGY VALUE
TOTAL TRIIODOTHYRONINE (T3) UNITS REFERENCE RANGE
TOTAL THYROXINE (T4) C.L.I.A 112 ng/dl 60-200
C.L.I.A 12.6
THYROID STIMULATING HORMONE (TSH) 1,.1g/dl 4.5-12
C.L.I.A 1.66 µIU/ml 0.3- 5.5
Comments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION
Please correlate with clinical conditions.
Method:

T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNOASSAY

T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNOASSAY
TSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY

le collected on (SCT)
samPle Received on (SRT)
: 11 Feb 2022 09:10
samPrt Released on (RRT) 11 Feb 2022 16: 15
11eP0
sample Type · 11 Feb 2022 21:31

Labcode
SERUM

sarcode 1102078556/AD962 Dr.Prachi Sinkar MD(Path)

Xl287630
Dr.Caesar Sengupta MD(Micro)
Page: 5 of 9
 PROCESSED AT:
Thyrocare
413, Block BI Thyro care
Chinarr fortune City, The Trust. The Truth.
Hoshangabad
- Road ,Bhopal-462 003

Corpora~ of/lt~ : Thy . .

© 022 • 3090 0000. / 6712 19 9870066333,
r,chnolotlM
f'OQtf3.COO Umllfd (> 0•.
37/1, TTC MIOt, Turbl)e, Navl Mumbai . 400 703
o111 www.thyrocarc.com
am wellntsst/11.hvrocart.com '-Ill

SAMPLE COLLECTED AT :
NAME : SMT SARLA PATHAK (81Y/F) ( 4 G100l0672),CHIRAG DIAGNOSTICS
REF.BY : SELF CENTRE,BETUL ROAD, P URANI ITARSI ITARSI
HOSHSNGABAD,461111 ' '
TEST ASKED : AAROGYAM B PRO

VALUE • UNITS
TECHNOLOGY 85 mL/mln/1.73 m2
TEST NAME CALCULATED
:seTf. GLOMERULAR FILTRATION RATE (eGFR)
erence Range :-

> = 90 : Normal
60 - 89 : Mild Decrease
: Mild to Moderate Decrease
45 - 59
: Moderate to Severe Decrease
30- 44
15 - 29 : Severe Decrease

Clinical Significance
11,e aocm•I ~rum '"'""'"e ,efenmtt lateNal do~ aot a&""rily ,efled a aom>•I GFR "" a ,,.,eat. •="'e mild ,ad modera<e
kldaeY loj,cv "poorly lofe,red fn,m ,erum ""'"'"' aloae. "'"''It;, '""'mmeoded fM dlalal >OoraOOri~ ro ro,tiadY estima<e
glomerul" ""ratioa ra>e (eGFR),, •gold ,raadanl" meaw,eme"' fM =essme"' of ,eaal ruoctiM, ,ad report the~'"' whee serum
aeatinlae ;, mea>""d to, pa<lee~ 18 ,ad olde<, whee appmpria<e ,ad feaslh<- n aoao< be mea>""' eaOly la dm;al practJtt,
lostead, GFR Is estimated from eqoatio~ "''"' ...,m "''""'"'' age, race ,ad~,."'"""""'~ easy to mte<P"" '"'°""'"'"
fo< the
docto< ,ad patieet oo the deg,ee of ,eaal lmpalm>eat ''"" It apPro,1ma<ely eq,ates to the pe=orage of kldO'Y '""'"'" ,emalolog.
APPllcatioo of CKD-EPI e'"'""' togethe< w<th the othe< a;,,,~,,
too•;, ~"'' medldae will rurthe< 1mp,-o.e the detedloo aad

management of patients with CKD.

Le,ey AS, ste,eo> LA, ,a.hmld CH, Zhao9 VL, ca~m AF, 3,d, feldmao HI, et al. A,_ eqoa,~ to estimate glomerula, filt,aOM rate-
Reference

Ann Intern Med, 2009;1S0(9):604-12,

please correlate with clinical conditions,
Method:- cKD-EPI creatinine Equation

: 11 Feb 2022 09:10

~ 1 e c t e d on (SCT)
: 11 Feb 2022 16:15
salf'IPle Received on (SRT)
: 11 Feb 2022 21:31
iteport Released on (RRT)
: SERUM Dr.Caesar Sengupta MD(Micro)
sarTIPle Type : 1102078556/AD962 Dr.Prachi Sinkar MD(Path)
u,bcode Page: 6 of9
: X1287630
earcode
pROCESSED AT:
Thyrocare
413 , Block B,
Ch lnarr Fortune City
Thyro care·
Hoshangabad Road B, h
, opal-462 00J The Tr1,1st. The Truth.
Corporotr of/kt : Thyroc.re Tecllnol
(9 022 . 3090 0000 / 67 12 l 400 @°'.let l Imllt d, 9 D-37/3, TTC MIDC, lur1Yhf1, Nav1Mumbai. 400 703
9870661.ll)J wellncu~1hvroc,1 rt .cam (!) www thyroure.t0m

NAME SMT SARLA PATHAK (BlY/F) SAMPLE COLLECTED AT :

REF. BY SELF (4610010672),CHIRAG DIAGNOSTICS
CENTRE,BETUL ROAD, P URANI ITARSI , ITARSI,
TEST ASKED HbAlc,HEMOGRAM HOSHSNGABAD,461111

TEST NAME TECHNOLOGY VALUE UNITS

HbAlc - (HPLC)
4.9 %
H.P.L.C
Referenc_
e Range:
Guidance For Known Diabetics
Reference Range: As per ADA Guidelines
Below 6.5% : Good Control
Below 5.7% : Normal
6.5% - 7% : Fair Control
5.7% - 6.4% : Prediabetic
7.0% - 8% : Unsatisfactory Control
>=6.5% : Diabetic
>8% : Poor Control i

Method : Full Automated H.P.L.C. usin Biorad Variant II Turbo

94 mg/di
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED
Reference Range :
90 - 120 mg/di : Good Control
121 - 150 mg/di : Fair Control
151 - 180 mg/di : Unsatisfactory Control
> 180 mg/di : Poor Control
Method : Derived from HBAlc values
Please correlate with clinical conditions.

salf'IPle collected on (SCT)

:11 Feb 2022 09:10
salf'IPle Received on (SRT)
: 11 Feb 2022 16:38
fleport Released on (RRT)
: 11 Feb 2022 19:oo
salf'lple Type
:EDTA
L,abcode
sarcode :11020B0373/ADg 62
Or.Prachi Sinkar MO(Path)
: X4263419 Dr.Caesar Sengupta MD(Miao)

Page: 7 of9
 pft 0
ocf5SED AT: Tbyrocare·
care B,
3, Block
"""'
41
The Trust. The Truth.
chinarr Fortune City,
Hoshangabad Road,Bhopal-46 2
003
r @ 022 . \NV\ OOOO / r t Ttchnolocjej Umlttd, 0•37/J TlC MIOCTurbhe, Navl Mumbai . 400 703
Cat(IOl'Ottoffett
· · ;,\r,N
:~
6712 3400 » 9B70666lll a w.ine,s@i"1'~"'·'°•
' I f. •"''•~•-«>•
SAMPLE COLLECTED AT:
(4610010672),CHIRAG DIAGNOSTICS RSI
NAME : SMT SARLA PATHAK (BlY/F) cENTRE,BfTUL ROAD, p uRANI !TARSI , !TA I
REF.BY : SELF HOSHSNGABAD,461111
TEST ASKED : HbAlc,HEMOGRAM
REFERENCE RANGE
UNITS
VALUE 4.0-10.0
X 103 I µL 40-80
TEST NAME 6,54
% 20.0-40,0
TOTAL LEUCOCYTES COUNT 68,2 o/a 0.0-10.0
NEUTROPHILS 19,7
% o.o-6.0
LYMPHOCYTE PERCENTAGE 6.6 % <2
4.4
MONOCYTES
0.8
% o.o-o.4
EOSINOPHILS % 2.0-7.0
0.3 X 103 I µL
BASOPHILS 1.0-3.0
IMMATURE GRANULOCVTE PERCENTAGE(JG%) 4.46 X103 / µL 0.2-1.0
1,29 X 103 I µL
NEUTROPHILS • ABSOLUTE COUNT 0.02-0.1
0,43 X 10 3 I µL
LYMPHOCYTES - ABSOLUTE COUNT 0.02-0.5
o.os X 10 3 I µL
MONOCYTES - ABSOLUTE COUNT
0.29
o.o-o.3
X 10 3 / µL 3.9-4,8
BASOPHILS • ABSOLUTE COUNT 0.02 X 10''6/µL <0.01
EOSJNOPHIL5 • ABSOLUTE COUNT
4.1 X 103 / µL
IMMATURE GRANULOCVTES(IG) <0.01
Nil % 12.0-15,0
TOTAL RBC Nil g/dL
NUCLEATED RED BLOOD CELLS 11,9
36.0-46.0
NUCLEATED RED BLOOD CELLS % % 83,0-101,0
38
92.7
fL 27.0-32,0
HEMOGLOBIN pQ 31.5-34,5
HEMATOCRIT(PCV) g/dL
MEAN coRPUSCULAR voLUME(MCV) 39,0-46.0
""'" coRPUSCUL/,R "'"oGL()BIN(MCH) 29 fL 11 .6-14.0
MEAII co••·"EMO.CONCCMcHC) 31., % 9.6-15.2
ED CELL 01srRJBUTION w,oT" • socRDW·SDl 13 8
.,
~. CfLL .,snuoun•• WIDTH (RDW•CVl ·
fL 6.5-12

•"""""noN wioTH(PDWl
fL 150-400
pLArEl£T ,., x103/JJL 19,7-42,4
0/o

--
"'" p[ArELff vocUHE(MPVl ;;~
18 0.19-0.39
%
0.29

..... ,.......,,,.,_
,.,.,,,,.. ,~•-"','" ......,. ,..
cELL ..TJO(PLCAI

...... ' "".........................

::;..,. ,_. ,........ ".....,,,,
pLATELffCR!T(:~clinical conditions, ..........
This device pe ( . g· a semiconductor laser), and sLS· hemoglobin method)

( ~ethod us1n
ey1:0 metrY -- End of report#-

1M
: 11 Feb 2022 09:10
e collected on (SCT) : 11 Feb 2022 16:38
Siill'IIP le iteceived on (SRT)
: 11 Feb 2022 19:00
s11111Prtl iteleased on (RRT)
: EDTA Dr.Caesar Sengupta MD(Micro)
11eP0 e rype 1,:1 'i1 ., 11:J
'i1 Dr.Prachi Sinkar MD(Path)
511111 Pi • I : 1102080373/AD962
: X4263419
Page : 8 of 9
L,lli,code
IJiilrcode